The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
- PMID: 22384518
- PMCID: PMC4062327
- DOI: 10.11613/bm.2012.005
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration
Abstract
Age-related macular degeneration (AMD) is a complex, degenerative and progressive disease involving the multiple genetic and environmental factors that can result in severe visual loss. The etiology of AMD is not well understood. Many theories exist and feature mechanisms of oxidative stress, atherosclerotic-like changes, genetic predisposition and inflammation. The most recent clinical studies appointed to a great role of inflammation and C-reactive protein (CRP) in the pathogenesis of AMD. There is a large body of evidence indicating the association of CRP with endothelial dysfunction, oxidative stress and production of reactive oxygen species (ROS), as well as with lipid status disorder in AMD patients. According to recent studies, CRP is definitely not only the inflammatory marker but also a mediator of development of the vascular disorders in the retinal circulation. The results obtained from the present studies may help our understanding the pathogenesis of the retinal vascular disease associated with high levels of CRP.
Makularna degeneracija povezana sa starošću (engl. age-related macular degeneration, AMD) kompleksna je, degenerativna i progresivna bolest koja uključuje višestruke genetske i okolišne čimbenike te može rezultirati ozbiljnim gubitkom vida. Etiologila AMD još se ne razumije u potpunosti. Postoje mnoge teorije koje ističu mehanizme oksidativnog stresa, promjene nalik na aterosklerotske promjene, genetske predispozicije i upalu. Najnovija klinička istraživanja proučavaju važnu ulogu upale i C-reaktivnog proteina (CRP) u patogenezi AMD. Postoji veliki broj dokaza koji ukazuju na povezanost CRP-a s endotelnom disfunkcijom, oksidativnim stresom i stvaranjem reaktivnih kisikovih spojeva kao i s poremećajem lipidnog statusa kod bolesnika oboljelih od AMD. Prema navodima novijih istraživanja CRP definitivno nije samo upalni biljeg, već i posrednik u razvoju vaskularnih poremećaja u retinalnoj cirkulaciji. Rezultati dobiveni nedavno provedenim istraživanjima mogu pomoći pri razumijevanju patogeneze retinalne vaskularne bolesti povezane s visokom koncentracijom CRP-a.
Similar articles
-
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.Br J Ophthalmol. 2011 Sep;95(9):1323-30. doi: 10.1136/bjo.2010.199216. Epub 2011 Jun 1. Br J Ophthalmol. 2011. PMID: 21633121 Free PMC article.
-
Oxidative Stress-Induced Pentraxin 3 Expression Human Retinal Pigment Epithelial Cells is Involved in the Pathogenesis of Age-Related Macular Degeneration.Int J Mol Sci. 2019 Nov 29;20(23):6028. doi: 10.3390/ijms20236028. Int J Mol Sci. 2019. PMID: 31795454 Free PMC article.
-
C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.Front Immunol. 2018 Apr 19;9:808. doi: 10.3389/fimmu.2018.00808. eCollection 2018. Front Immunol. 2018. PMID: 29725335 Free PMC article. Review.
-
[The age-related macular degeneration as a vascular disease/part of systemic vasculopathy: contributions to its pathogenesis].Orv Hetil. 2015 Mar 1;156(9):358-65. doi: 10.1556/OH.2015.30017. Orv Hetil. 2015. PMID: 25702256 Review. Hungarian.
-
Use of blood markers in early diagnosis of oxidative stress in age related macular degeneration.Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1136-42. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23700902
Cited by
-
NLRP3 and autophagy in retinal ganglion cell inflammation in age-related macular degeneration: potential therapeutic implications.Int J Ophthalmol. 2024 Aug 18;17(8):1531-1544. doi: 10.18240/ijo.2024.08.20. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39156786 Free PMC article. Review.
-
Associations of sleep apnoea with glaucoma and age-related macular degeneration: an analysis in the United Kingdom Biobank and the Canadian Longitudinal Study on Aging.BMC Med. 2021 May 11;19(1):104. doi: 10.1186/s12916-021-01973-y. BMC Med. 2021. PMID: 33971878 Free PMC article.
-
Interleukin-1β Level Is Increased in Vitreous of Patients with Neovascular Age-Related Macular Degeneration (nAMD) and Polypoidal Choroidal Vasculopathy (PCV).PLoS One. 2015 May 15;10(5):e0125150. doi: 10.1371/journal.pone.0125150. eCollection 2015. PLoS One. 2015. PMID: 25978536 Free PMC article.
-
The Efficacy and Safety of Brolucizumab for the Treatment of nAMD: A Systematic Review and Meta-Analysis.Front Pharmacol. 2022 May 13;13:890732. doi: 10.3389/fphar.2022.890732. eCollection 2022. Front Pharmacol. 2022. PMID: 35645802 Free PMC article.
-
CETP/LPL/LIPC gene polymorphisms and susceptibility to age-related macular degeneration.Sci Rep. 2015 Oct 27;5:15711. doi: 10.1038/srep15711. Sci Rep. 2015. PMID: 26503844 Free PMC article.
References
-
- Gu J, Pauer GJT, Yue X, Narendra U, Sturgill GM, Bena J, et al. Proteomic and Genomic Biomarkers for Age-Related Macular Degeneration. Adv Exp Med Biol. 2010;664:411–7. - PubMed
-
- Edwards AO, Ritter R, III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421–4. - PubMed
-
- Nowak J. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353–63. - PubMed
-
- Seddon J, Gensler G, Milton R, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291:704–10. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous